Radiotherapy of chloroma or granulocytic sarcoma: A literature review

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
S YossiA d'Hombres

Abstract

Granulocytic sarcoma, or chloroma, is a rare clinical entity, usually associated with a blood disease, including acute myeloid leukemia. Management strategies are based on the combination of systemic therapy and local therapy (surgery or radiation). Data for radiotherapy dose are derived from retrospective studies and case reports. We conducted a literature review using the Pubmed search engine to clarify the terms and indications for radiotherapy of chloromas.

References

Dec 15, 1986·Cancer·J M MeisJ T Manning
Aug 1, 1983·International Journal of Radiation Oncology, Biology, Physics·L Y ChakR S Cox
Sep 1, 1995·Annals of Internal Medicine·K R ImrieA Keating
Mar 1, 1994·Radiology·M H PuiJ W Langston
Oct 14, 2000·Journal of the European Academy of Dermatology and Venereology : JEADV·A PulsoniL Muscardin
Mar 11, 2003·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Katharina FleckensteinMichael Molls
Mar 11, 2004·British Journal of Haematology·Isao MiyoshiYuji Ohtsuki
Sep 9, 2006·Internal Medicine Journal·M W PitzM D Seftel
Oct 27, 2006·Leukemia & Lymphoma·Isabel Cunningham
Dec 16, 2006·Leukemia & Lymphoma·Semra PaydasMelek Ergin
Mar 30, 2007·European Journal of Haematology·Jyoti KumarSeema Sen
May 19, 2007·European Journal of Haematology·Vassilios VassiliouPanagiota Matsouka
Jun 21, 2007·AJR. American Journal of Roentgenology·Jan FritzMarius Horger
May 24, 2008·International Journal of Hematology·Mirta KoželjSamo Zver
Jul 8, 2008·Journal of the Peripheral Nervous System : JPNS·Michelle L MauermannP James B Dyck
Jul 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrice ChevallierJean-Luc Harousseau
Dec 26, 2008·International Journal of Hematology·Darko AnticLjubomir Jakovic
Nov 26, 2009·Journal of Pediatric Hematology/oncology·John E MignanoLawrence C Wolfe
Jun 4, 2011·Hematological Oncology·Batia AvniOra Paltiel
Jun 21, 2011·Haematologica·Friedrich StölzelMarkus Schaich
Jul 29, 2011·Blood·Richard L BakstJoachim Yahalom
Oct 4, 2011·International Journal of Radiation Oncology, Biology, Physics·Richard BakstJoachim Yahalom
Dec 12, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Darko AnticDragica Tomin
Oct 1, 2011·Therapeutic Advances in Hematology·Batia Avni, Maya Koren-Michowitz
Oct 24, 2013·Radiation Oncology·Wan-Yu ChenAnn-Lii Cheng
Dec 26, 2013·International Medical Case Reports Journal·Prakash VishnuDavid M Aboulafia
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew C HooverMark C Smith

❮ Previous
Next ❯

Citations

Oct 26, 2018·PloS One·Sheau C ChaiBahram H Arjmandi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Richard BakstJoachim Yahalom
The American Journal of the Medical Sciences
B R Mullin, J W Harris
Annales de dermatologie et de vénéréologie
F MalthieuG Guillet
© 2022 Meta ULC. All rights reserved